After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
IMNM belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Immunome Inc is $748.20M. A total of 0.57 million shares were traded on the day, compared to an average of 796.98K shares.
In the most recent transaction, SIEGALL CLAY B bought 66,057 shares of IMNM for 9.54 per share on Nov 21 ’24. After the transaction, the President and CEO now owns 485,693 company shares. In a previous transaction on Nov 22 ’24, SIEGALL CLAY B bought 33,943 shares at 9.78 per share. IMNM shares that President and CEO owns now total 519,636.
Among the insiders who bought shares, Lechleider Robert acquired of 15,805 shares on Nov 21 ’24 at a per-share price of $9.48. This resulted in the Chief Medical Officer holding 15,805 shares of IMNM after the transaction. In another insider transaction, Tsai Philip bought 21,000 shares at $9.43 per share on Nov 21 ’24. Company shares held by the Chief Technology Officer now total 21,000.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, IMNM has a high of $30.96 and a low of $8.97.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. IMNM’s latest balance sheet shows that the firm has $49.23M in Cash & Short Term Investments as of fiscal 2021. There were $317.00k in debt and $9.73M in liabilities at the time. Its Book Value Per Share was $3.56, while its Total Shareholder’s Equity was $48.19M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IMNM is Buy with a score of 5.00.
